It provides information on the test gene, and provides detailed information to the log-in user.
| No. | Ingredient name | Drug classification | Main diseases | Genetic biomarkers |
|---|---|---|---|---|
| 171 | Irinotecan |
Anticancer Drugs | Metastatic rectal cancer, colon cancer, gastric cancer, small cell lung cancer, advanced non-small cell lung cancer | UGT1A1 |
| 172 | Azathioprine |
Immunosuppressive antimetabolite | Inhibition of rejection after kidney transplant, autoimmune disease | NUDT15 , TPMT |
| 173 | Cisplatin |
Anticancer Drugs | Testicular cancer, bladder cancer, prostate cancer, ovarian cancer, head and neck cancer, lung cancer, esophageal cancer, stomach cancer, cervical cancer, pediatric cancer | TPMT |
| 174 | Mercaptopurine |
Anticancer Drugs | Acute leukemia, chronic myelogenous leukemia | NUDT15 , TPMT |
| 175 | Lapatinib |
Anticancer Drugs | Breast cancer | HLA-DQA1 , HLA-DRB1 |
| 176 | Rasburicase |
Recombinant Enzymes | Hyperuricemia in patients with malignant tumor | G6PD |
| 177 | Tacrolimus |
Immunosuppressive antimetabolite | Inhibition of rejection in renal / liver transplantation, chronic rheumatoid arthritis, lupus nephritis | CYP3A5 |
| 178 | Phenytoin |
Anticonvulsants | Epilepsy, generalized tonic-clonic seizure, focal seiqure, psychomotor seizures | CYP2C9 , HLA-B |
| 179 | Carbamazepine |
Anticonvulsants | Epilepsy, trigeminal neuralgia, mania, manic depressive condition, excited state of schizophrenia | HLA-A , HLA-B |
| 180 | Oxcarbazepine |
Anticonvulsants | Epilepsy, partial seizures, generalized tonic-clonic seizure | HLA-B |
Drag left and right